MYX's nice juicy purchase just gives it plenty on the balance sheet that can be written down if it can't convert "potential" into actual sales...
Unfortunately the market doesn't have much faith in their ability to infiltrate the market in a timely manner atm and all current results will show is them underperforming still in existing generics.
- Forums
- ASX - By Stock
- MYX
- General Discussion Topics
MYX
mayne pharma group limited
Add to My Watchlist
1.00%
!
$5.07

General Discussion Topics, page-29
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$5.07 |
Change
0.050(1.00%) |
Mkt cap ! $411.9M |
Open | High | Low | Value | Volume |
$5.00 | $5.14 | $4.94 | $712.4K | 141.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 1059 | $5.07 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$5.13 | 1000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 1059 | 5.070 |
3 | 4888 | 5.050 |
2 | 3150 | 5.040 |
2 | 1660 | 5.030 |
1 | 1060 | 5.020 |
Price($) | Vol. | No. |
---|---|---|
5.130 | 1000 | 1 |
5.140 | 215 | 1 |
5.150 | 10000 | 1 |
5.160 | 2000 | 1 |
5.170 | 1060 | 1 |
Last trade - 16.10pm 26/06/2025 (20 minute delay) ? |
Featured News
MYX (ASX) Chart |
The Watchlist
PTX
PRESCIENT THERAPEUTICS LIMITED
James McDonnell, CEO
James McDonnell
CEO
Previous Video
Next Video
SPONSORED BY The Market Online